CAPR News

CAPR Investigation Reminder: Capricor Therapeutics Securities Fraud Investigation Over Alleged Misrepresentations is Ongoing - Investors Urged to Protect Your Rights

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Capricor Therapeutics, Inc. (CAPR) And Encourages Investors to Reach Out

CAPR SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Capricor Therapeutics, Inc. for Possible Securities Law Violations

Capricor Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Capricor Therapeutics, Inc. (CAPR)

Law Offices of Howard G. Smith Encourages Capricor Therapeutics, Inc. (CAPR) Shareholders To Inquire About Securities Fraud Class Action

Securities Fraud Investigation Into Capricor Therapeutics, Inc. (CAPR) Announced Concerning FDA Review And Advisory Committee Meeting – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

CAPR Investor Alert: Levi & Korsinsky Investigates Capricor Therapeutics, Inc. (CAPR) for Potential Securities Fraud

$CAPR Securities: Suffer Losses on Your Capricor Therapeutics Investment? BFA Law Notifies Investors of the Securities Fraud Lawsuit to Recover Losses

CAPR CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Capricor Therapeutics, Inc.

CAPR CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit on Behalf of Capricor Therapeutics, Inc.